NASDAQ:BPMC
Blueprint Medicines
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.blueprintmedicines.comipo date
Apr 30, 2015
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advan...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus